• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Erectile Dysfunction Devices Market

    ID: MRFR/HC/41636-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Erectile Dysfunction Devices Market Research Report By Device Type (Vacuum Erection Devices, Penile Implants, Injection Therapy Devices, Topical Drug Delivery Devices), By End User (Home Use, Medical Institutions, Pharmacies), By Patient Type (Primary Erectile Dysfunction, Secondary Erectile Dysfunction), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Erectile Dysfunction Devices Market Infographic
    Purchase Options

    Erectile Dysfunction Devices Market Summary

    The Global Erectile Dysfunction Devices Market is projected to grow from 5.41 USD Billion in 2024 to 10.5 USD Billion by 2035.

    Key Market Trends & Highlights

    Erectile Dysfunction Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 6.21 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 10.5 USD Billion, indicating robust growth.
    • In 2024, the market is valued at 5.41 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of innovative erectile dysfunction devices due to increasing awareness and acceptance of sexual health is a major market driver.

    Market Size & Forecast

    2024 Market Size 5.41 (USD Billion)
    2035 Market Size 10.5 (USD Billion)
    CAGR (2025-2035) 6.21%

    Major Players

    VIVUS, Suneva Medical, Aytu BioScience, CaverStem, Sexual Health Innovations, Neos Therapeutics, Pfizer, Coloplast, Endo Pharmaceuticals, Ereca, Boston Scientific, Bayer, Astellas Pharma, Medtronic, Uromed, Inc.

    Erectile Dysfunction Devices Market Trends

    The global market for erectile dysfunction devices is being driven by various key factors. Increasing awareness about men's health issues, coupled with a growing number of patients seeking treatment for erectile dysfunction, has led to a rise in the demand for these devices. Technological advancements in medical devices, including more effective and user-friendly options, have also contributed to market growth.

    Additionally, the rising prevalence of diabetes, cardiovascular diseases, and obesity further fuels the demand for erectile dysfunction solutions. This underscores the need for effective treatments tailored to address these underlying health issues. Significant opportunities exist in the market that companies can explore to enhance their offerings. The integration of telemedicine and digital health solutions provides a unique avenue for expanding access to treatment for erectile dysfunction.

    Furthermore, the increasing acceptance of advanced therapies, such as low-intensity shockwave therapy and vacuum erection devices, opens new doors for innovation. As lifestyle changes continue to shift perspectives on sexual health, companies can also tap into emerging markets in developing regions, where awareness and acceptance of such devices are on the rise. Recent trends in the erectile dysfunction devices market show a shift toward more personalized treatment options.

    The focus on men's health is becoming more mainstream, encouraging discussions around erectile dysfunction. This acceptance has led to an increase in online platforms where individuals can seek guidance and purchase devices discreetly. Moreover, marketing efforts have begun to emphasize the psychological aspects of erectile dysfunction, addressing the emotional barriers men face when considering treatment. As the market evolves, it is likely we will see continued growth driven by technological innovation and an increasing emphasis on holistic approaches to men's health.

    The increasing prevalence of erectile dysfunction, coupled with advancements in medical technology, appears to be driving a notable expansion in the market for erectile dysfunction devices, reflecting a growing recognition of men's health issues.

    U.S. National Institutes of Health

    Erectile Dysfunction Devices Market Drivers

    Aging Population

    The aging population is a crucial driver of the Global Erectile Dysfunction Devices Market Industry. As life expectancy increases, the number of older men susceptible to erectile dysfunction rises correspondingly. This demographic shift necessitates effective treatment options to address the unique health challenges faced by older adults. With a significant portion of the population over the age of 60, the demand for erectile dysfunction devices is likely to escalate. The market's growth is further supported by healthcare systems adapting to cater to this demographic, ensuring that effective solutions are accessible. This trend underscores the importance of addressing the needs of an aging population within the Global Erectile Dysfunction Devices Market Industry.

    Market Growth Projections

    Increased Awareness and Acceptance

    Increased awareness and societal acceptance of erectile dysfunction contribute significantly to the growth of the Global Erectile Dysfunction Devices Market Industry. Public discussions and educational campaigns have reduced the stigma associated with this condition, encouraging men to seek help. Healthcare providers are also more proactive in addressing erectile dysfunction, leading to higher diagnosis rates. This shift in perception is reflected in the growing number of patients seeking treatment, which is expected to drive market growth. As the industry adapts to these changing attitudes, the market is projected to experience a compound annual growth rate of 6.21% from 2025 to 2035, highlighting the evolving landscape of the Global Erectile Dysfunction Devices Market Industry.

    Rising Prevalence of Erectile Dysfunction

    The Global Erectile Dysfunction Devices Market Industry is experiencing growth due to the increasing prevalence of erectile dysfunction among men, particularly in older demographics. Statistics indicate that approximately 52 percent of men aged 40 to 70 experience some degree of erectile dysfunction. This rising incidence is attributed to various factors, including lifestyle changes, chronic diseases, and psychological issues. As awareness of this condition grows, more individuals seek treatment options, thereby driving demand for erectile dysfunction devices. The market is projected to reach 5.41 USD Billion in 2024, reflecting the urgent need for effective solutions in the Global Erectile Dysfunction Devices Market Industry.

    Growing Investment in Healthcare Infrastructure

    Growing investment in healthcare infrastructure globally enhances the accessibility of erectile dysfunction treatments, thereby benefiting the Global Erectile Dysfunction Devices Market Industry. Governments and private sectors are increasingly allocating resources to improve healthcare facilities and services, particularly in developing regions. This investment facilitates better diagnosis and treatment options for erectile dysfunction, making devices more available to those in need. Enhanced healthcare infrastructure also supports the training of healthcare professionals, ensuring they are equipped to address erectile dysfunction effectively. As a result, the market is poised for growth, reflecting the positive impact of improved healthcare systems on the Global Erectile Dysfunction Devices Market Industry.

    Technological Advancements in Treatment Options

    Technological innovations play a pivotal role in the Global Erectile Dysfunction Devices Market Industry. The introduction of advanced devices, such as vacuum erection devices and penile implants, has transformed treatment methodologies. These devices are designed to be more user-friendly and effective, enhancing patient satisfaction. For instance, recent developments in inflatable penile prostheses offer improved functionality and comfort. As technology continues to evolve, it is likely that new devices will emerge, further expanding the market. The anticipated growth trajectory suggests that the market could reach 10.5 USD Billion by 2035, indicating a robust demand for innovative solutions in the Global Erectile Dysfunction Devices Market Industry.

    Market Segment Insights

    Erectile Dysfunction Devices Market Device Type Insights

    The Global Erectile Dysfunction Devices Market is witnessing a steady growth trajectory, particularly within its Device Type segment, which comprises Vacuum Erection Devices, Penile Implants, Injection Therapy Devices, and Topical Drug Delivery Devices. By the year 2024, the market is expected to be valued significantly, with Vacuum Erection Devices capturing substantial interest, valued at 1.26 USD Billion, showcasing their efficacy in assisting men with erectile dysfunction through a non-invasive method. This innovative device holds a prominent position due to its ease of use and effectiveness, contributing to a notable percentage of the market.

    Meanwhile, Penile Implants, valued at 2.15 USD Billion in 2024, dominate the market, representing a major share of the Global Erectile Dysfunction Devices Market revenue. The increasing prevalence of erectile dysfunction among males, particularly in the aging population, is a key driver behind the growth of this segment, as these implants provide a long-term solution for individuals seeking a permanent resolution to their condition.

    Further, Injection Therapy Devices account for a significant market valuation of 1.25 USD Billion in 2024. Known for their targeted delivery of medications, these devices are gaining popularity among patients who prefer a discreet and effective treatment option. The relatively straightforward administration of injections allows for enhanced intimacy without the prolonged waiting times associated with other methods, bolstering their appeal in the market. In contrast, Topical Drug Delivery Devices will be valued at 0.75 USD Billion in 2024, making this segment the least dominant among its counterparts.

    However, their significance cannot be underestimated, as these devices offer varying mechanisms to administer medication directly to the affected area, appealing particularly to those seeking alternative methods to achieve satisfactory sexual performance. As the Global Erectile Dysfunction Devices Market segmentation evolves, it reflects changing consumer preferences that lean towards minimally invasive treatments, with each device type catering to different therapeutic needs.

    The projected growth signifies an expanding understanding of erectile dysfunction and growing market acceptance of innovative devices, leading to heightened demand and diversified product offerings. Consequently, the industry is focusing on developing more advanced and patient-friendly devices to address the requirements of a broader demographic while overcoming challenges such as product awareness and affordability. Overall, the Device Type landscape is vibrant, with opportunities flourishing as manufacturers and healthcare providers seek to deliver effective and sustainable solutions to enhance the quality of life for affected individuals.

    Erectile Dysfunction Devices Market End User Insights

    The Global Erectile Dysfunction Devices Market is projected to be valued at 5.41 billion USD by 2024, showcasing a significant growing demand driven by increasing awareness and acceptance of related health issues. Within the End User segment, the distribution of devices comprises Home Use, Medical Institutions, and Pharmacies, each playing a crucial role in market dynamics. Home Use is gaining traction as more individuals opt for discreet solutions, enhancing convenience and comfort. Medical Institutions represent a critical channel, providing professional care and direct access to advanced devices for diagnoses and treatments.

    Pharmacies serve a vital function by ensuring widespread accessibility to these devices, catering to the needs of consumers, and contributing to increasing market penetration. This diversity across the End User segment allows for varied consumer engagement strategies and highlights the importance of each category in delivering effective solutions in the Global Erectile Dysfunction Devices Market. As the market continues to expand, these sections are expected to experience growth driven by changing lifestyle factors and the growing prevalence of erectile dysfunction.

    Erectile Dysfunction Devices Market Patient Type Insights

    The Global Erectile Dysfunction Devices Market is characterized by a diverse segmentation based on Patient Type, which is crucial for understanding market dynamics. In 2024, the market is expected to be valued at approximately 5.41 billion USD, highlighting its substantial growth potential. Within this segment, Primary Erectile Dysfunction is a significant contributor, as it often encompasses cases arising from psychological factors and lifestyle issues, which are increasingly prevalent in modern society. Furthermore, Secondary Erectile Dysfunction represents a considerable share, attributed to underlying health problems or medical conditions that impact sexual function.

    The rising prevalence of conditions such as diabetes and cardiovascular diseases is likely propelling the demand within this segment, reflecting market growth opportunities. The integration of advanced technologies in devices catering to these patient types is also fostering innovation and enhancing treatment methods. Additionally, the growing awareness and acceptance of erectile dysfunction treatments are contributing to a positive outlook for the Global Erectile Dysfunction Devices Market. Overall, these insights indicate a healthy trajectory for the market, driven by both the Primary and Secondary Erectile Dysfunction categories, each with its set of unique challenges and opportunities.

    Erectile Dysfunction Devices Market Distribution Channel Insights

    The Global Erectile Dysfunction Devices Market is witnessing a significant transformation in its distribution channel landscape, driven by increasing consumer demand for accessible and discreet solutions. By 2024, the market is expected to be valued at 5.41 billion USD. The market encompasses various distribution channels, notably Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies, each contributing uniquely to market dynamics. Online Pharmacies have emerged as a prominent channel, attracting a substantial share of the market due to their convenience and anonymity, which resonate well with consumers seeking discretion.

    Retail Pharmacies continue to dominate, providing immediate access and the ability to consult pharmacists, thus playing a crucial role in customer engagement and education. Hospital Pharmacies, while holding a significant yet smaller share, are essential for providing specialized care and treatment options within clinical settings.

    As the market evolves, trends such as increased telemedicine and rising health awareness are expected to further influence these distribution channels, presenting opportunities for growth and addressing challenges such as regulatory compliance and competition among providers. The Global Erectile Dysfunction Devices Market data illustrates a positive growth outlook, with the segment poised for ongoing expansion driven by these dynamics.

    Get more detailed insights about Erectile Dysfunction Devices Market Research Report — Global Forecast till 2035

    Regional Insights

    The Global Erectile Dysfunction Devices Market is poised for growth across various regions, with North America leading the way, holding a valuation of 2.16 USD Billion in 2024, which is expected to rise to 4.2 USD Billion by 2035. This region is majorly dominating due to advanced healthcare infrastructure and higher awareness of ED treatment options.

    Europe follows with a valuation of 1.78 USD Billion in 2024 and is projected to attain 3.5 USD Billion by 2035, driven by aging populations and increased healthcare expenditure. The APAC region, valued at 1.2 USD Billion in 2024 and expected to reach 2.4 USD Billion by 2035, also shows significant growth potential, fueled by rising disposable incomes and a growing focus on men's health issues.

    In contrast, South America and MEA remain the least dominant regions, with valuations of 0.15 USD Billion and 0.12 USD Billion in 2024, respectively. However, both regions present opportunities for market growth as awareness of erectile dysfunction issues increases and healthcare access improves. The Global Erectile Dysfunction Devices Market revenue reflects diverse growth drivers specific to each region, influenced by demographic trends, economic factors, and cultural attitudes toward sexual health. Overall, regional dynamics play a crucial role in shaping the Global Erectile Dysfunction Devices Market statistics and growth trajectories.

    Erectile Dysfunction Devices Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Erectile Dysfunction Devices Market is characterized by its dynamic nature, influenced by a blend of technological advancements and changing consumer preferences. As the awareness surrounding erectile dysfunction increases, the market is becoming increasingly competitive, with new entrants and established players striving for a larger share.

    The shift towards non-invasive treatment options alongside a growing acceptance of medical devices among the male population signifies a potential for significant growth in this sector. Companies are focusing on innovative product developments and strategic partnerships to enhance their market footprint, creating a landscape of vigorous competition and evolving offerings tailored to meet the diverse needs of patients.

    VIVUS stands out in the Global Erectile Dysfunction Devices Market due to its strong emphasis on innovation and patient-centered solutions. The company's portfolio encompasses a range of devices designed to provide effective treatment options for erectile dysfunction. VIVUS has established its presence with a robust reputation for developing high-quality, clinically proven devices that cater to varying degrees of erectile dysfunction.

    Its commitment to research and development has fortified its position as a leader in the market, with an extensive understanding of patient needs ensuring that its offerings are competitive and continuously evolving. Furthermore, VIVUS’s strategic collaborations and partnerships enhance its market visibility, enabling it to leverage the latest technologies and expand its reach within the erectile dysfunction device landscape.

    Suneva Medical is gaining traction in the Global Erectile Dysfunction Devices Market, focusing on innovative solutions that combine cosmetic enhancements with therapeutic benefits. The company is notable for its commitment to advancing treatment methodologies for erectile dysfunction, producing devices that are not only effective but also user-friendly. Suneva Medical's products are designed with the latest technological advancements, which support its goal of providing comprehensive solutions for male sexual health.

    The brand emphasizes the importance of patient education and satisfaction, leading to a strong reputation built on trust and effectiveness. By concentrating on patient-centric approaches and maintaining high standards for product quality, Suneva Medical differentiates itself in a competitive landscape filled with various alternatives for treating erectile dysfunction.

    Key Companies in the Erectile Dysfunction Devices Market market include

    Industry Developments

    • Q2 2024: Boston Scientific Announces FDA Approval of AMS 700™ Inflatable Penile Prosthesis with New Hydrophilic Coating Boston Scientific received FDA approval for its updated AMS 700™ inflatable penile prosthesis featuring a new hydrophilic coating designed to reduce infection risk and improve surgical outcomes for erectile dysfunction patients.
    • Q1 2024: Coloplast Launches Titan Touch™ Penile Implant in the United States Coloplast announced the commercial launch of its Titan Touch™ penile implant in the U.S., offering enhanced ease of use for both surgeons and patients seeking surgical solutions for erectile dysfunction.
    • Q2 2024: Zephyr Surgical Implants Secures CE Mark for ZSI 475 Hydraulic Penile Prosthesis Zephyr Surgical Implants received CE Mark approval for its ZSI 475 hydraulic penile prosthesis, allowing the device to be marketed and sold across the European Union for the treatment of erectile dysfunction.
    • Q3 2024: Boston Scientific Expands Penile Implant Manufacturing Facility in Minnesota Boston Scientific announced the expansion of its penile implant manufacturing facility in Minnesota to meet growing demand for erectile dysfunction devices in North America and globally.
    • Q2 2024: UroMems Raises $47 Million in Series C Funding to Advance Smart Implantable Devices for Erectile Dysfunction UroMems closed a $47 million Series C funding round to accelerate the development and clinical trials of its smart implantable devices for the treatment of erectile dysfunction.
    • Q1 2024: Coloplast Receives FDA Clearance for Next-Generation Genesis™ Malleable Penile Prosthesis Coloplast received FDA clearance for its next-generation Genesis™ malleable penile prosthesis, designed to provide improved durability and patient comfort for men with erectile dysfunction.
    • Q2 2025: Boston Scientific Acquires European ED Device Startup MedErect for $120 Million Boston Scientific completed the acquisition of MedErect, a European startup specializing in minimally invasive erectile dysfunction devices, to expand its product portfolio and strengthen its presence in the global ED market.
    • Q1 2025: UroMems Announces First-in-Human Implantation of UroActive™ Smart Penile Prosthesis UroMems reported the successful first-in-human implantation of its UroActive™ smart penile prosthesis, marking a milestone in the development of next-generation, sensor-enabled erectile dysfunction devices.
    • Q3 2024: Boston Scientific Appoints Dr. Michael Chen as Vice President of Erectile Restoration Division Boston Scientific announced the appointment of Dr. Michael Chen as Vice President of its Erectile Restoration Division, responsible for leading innovation and global strategy in the erectile dysfunction devices sector.
    • Q2 2024: Coloplast Signs Distribution Agreement with Medtronic for Penile Implants in Asia-Pacific Coloplast entered into a distribution agreement with Medtronic to expand the availability of its penile implant devices across key Asia-Pacific markets, aiming to increase access to surgical solutions for erectile dysfunction.
    • Q1 2025: UroMems Opens New R&D Center in Paris to Accelerate ED Device Innovation UroMems inaugurated a new research and development center in Paris dedicated to advancing smart implantable devices for erectile dysfunction, supporting ongoing clinical trials and product development.
    • Q2 2025: Coloplast Announces Strategic Partnership with Telehealth Provider Hims & Hers for ED Device Consultations Coloplast formed a strategic partnership with Hims & Hers to offer virtual consultations and expand patient access to its erectile dysfunction devices through telehealth channels in the United States.

    Future Outlook

    Erectile Dysfunction Devices Market Future Outlook

    The Erectile Dysfunction Devices Market is projected to grow at a 6.21% CAGR from 2024 to 2035, driven by technological advancements, increasing awareness, and a growing aging population.

    New opportunities lie in:

    • Develop telehealth platforms for remote consultations and device prescriptions.
    • Invest in R&D for innovative, user-friendly devices targeting younger demographics.
    • Expand distribution channels through partnerships with pharmacies and online retailers.

    By 2035, the market is poised for robust growth, reflecting increased accessibility and consumer acceptance.

    Market Segmentation

    Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Erectile Dysfunction Devices Market End User Outlook

    • Home Use
    • Medical Institutions
    • Pharmacies

    Erectile Dysfunction Devices Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Erectile Dysfunction Devices Market Device Type Outlook

    • Vacuum Erection Devices
    • Penile Implants
    • Injection Therapy Devices
    • Topical Drug Delivery Devices

    Erectile Dysfunction Devices Market Patient Type Outlook

    • Primary Erectile Dysfunction
    • Secondary Erectile Dysfunction

    Erectile Dysfunction Devices Market Distribution Channel Outlook

    • Online Pharmacies
    • Retail Pharmacies
    • Hospital Pharmacies

    Report Scope

     
    Attribute/Metric Source: Details
    MARKET SIZE 2023 5.09 (USD Billion)
    MARKET SIZE 2024 5.41 (USD Billion)
    MARKET SIZE 2035 10.5 (USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.22% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2023
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED VIVUS, Suneva Medical, Aytu BioScience, CaverStem, Sexual Health Innovations, Neos Therapeutics, Pfizer, Coloplast, Endo Pharmaceuticals, Ereca, Boston Scientific, Bayer, Astellas Pharma, Medtronic, Uromed, Inc.
    SEGMENTS COVERED Device Type, End User, Patient Type, Distribution Channel, Regional
    KEY MARKET OPPORTUNITIES Increasing prevalence of erectile dysfunction, Advancements in device technology, Rising awareness and acceptance, Growing geriatric population, Expanding telehealth services for treatment
    KEY MARKET DYNAMICS Increasing prevalence of erectile dysfunction, Growing awareness and acceptance, Technological advancements in devices, Aging population and lifestyle changes, Rising disposable income and healthcare spending
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA

    FAQs

    What is the expected market size of the Global Erectile Dysfunction Devices Market in 2024?

    The Global Erectile Dysfunction Devices Market is expected to be valued at 5.41 USD Billion in 2024.

    What is the anticipated value of the Global Erectile Dysfunction Devices Market by 2035?

    By 2035, the Global Erectile Dysfunction Devices Market is anticipated to reach a value of 10.5 USD Billion.

    What is the expected compound annual growth rate (CAGR) for the Global Erectile Dysfunction Devices Market between 2025 and 2035?

    The expected CAGR for the Global Erectile Dysfunction Devices Market from 2025 to 2035 is 6.22%.

    Which region is projected to have the largest market share in the Global Erectile Dysfunction Devices Market in 2024?

    North America is projected to have the largest market share in the Global Erectile Dysfunction Devices Market with a value of 2.16 USD Billion in 2024.

    What will be the market size for Vacuum Erection Devices in 2035?

    The market size for Vacuum Erection Devices is projected to be valued at 2.51 USD Billion in 2035.

    Which key players are leading the Global Erectile Dysfunction Devices Market?

    Key players in the Global Erectile Dysfunction Devices Market include VIVUS, Aytu BioScience, Coloplast, and Boston Scientific.

    What is the expected market size of Penile Implants in 2024?

    The expected market size of Penile Implants in 2024 is 2.15 USD Billion.

    Which region is anticipated to see the smallest market size by 2035?

    South America is anticipated to see the smallest market size with a projected value of 0.3 USD Billion by 2035.

    What is the expected market valuation for Injection Therapy Devices in 2035?

    The expected market valuation for Injection Therapy Devices in 2035 is 2.45 USD Billion.

    What growth opportunities exist for the Global Erectile Dysfunction Devices Market?

    Growth opportunities in the Global Erectile Dysfunction Devices Market are driven by increasing awareness and advancements in treatment options.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials